GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » Research & Development

Origin Therapeutics Holdings (XCNQ:ORIG) Research & Development : C$0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Origin Therapeutics Holdings's Research & Development for the three months ended in Jun. 2023 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.


Origin Therapeutics Holdings Research & Development Historical Data

The historical data trend for Origin Therapeutics Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Research & Development Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
Research & Development
- -

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Research & Development Get a 7-Day Free Trial Premium Member Only - - - - -

Origin Therapeutics Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Origin Therapeutics Holdings  (XCNQ:ORIG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Origin Therapeutics Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Origin Therapeutics Holdings (XCNQ:ORIG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

Origin Therapeutics Holdings (XCNQ:ORIG) Headlines

From GuruFocus

Ocean Rig UDW Inc. Announces Updates to Rig Employment

By Marketwired Marketwired 07-23-2018

Third Avenue Management Comments on Ocean Rig UDW

By Holly LaFon Holly LaFon 11-01-2018

Strong Results Makes Ocean Rig Attractive

By Faisal Humayun Faisal Humayun 11-10-2014

Bullish Developments Continue For Ocean Rig

By Faisal Humayun Faisal Humayun 06-30-2014

Ocean Rig UDW Inc Joins the Russell 3000® Index

By Marketwired Marketwired 06-26-2018

Remain Cautious On Ocean Rig

By Faisal Humayun Faisal Humayun 04-16-2015

5 Energy Stocks in Gurus' Portfolios

By Tiziano Frateschi Tiziano Frateschi 06-01-2018